Systemic lupus erythematosus
RecruitingStudy on the Safety and Effectiveness of CABA-201, Fludarabine Phosphate, and Cyclophosphamide in Patients with Active Systemic Lupus Erythematosus
Study on the Safety and Effectiveness of CABA-201, Fludarabine Phosphate, and Cyclophosphamide in Patients with Active Systemic Lupus Erythematosus
- Disease:Systemic lupus erythematosus
- Substances:CyclophosphamideCyclophosphamide Monohydrate+1
France- Participants:0–17 years · 18–64 years · 65+ years
- Substances:Cyclophosphamide
- Sponsor:Cabaletta Bio Inc.




